Vivos Therapeutics, Inc. (VVOS) Operating income 2019–2025
Vivos Therapeutics, Inc. (VVOS) annual operating income history from SEC filings — each fiscal year as reported.
-$19.9MFY2025 · since FY2019: -$10.6M → -$19.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$19.9M | -78.1% |
| FY2024 | -$11.2M | +35.4% |
| FY2023 | -$17.3M | +30.9% |
| FY2022 | -$25.0M | -22.8% |
| FY2021 | -$20.4M | -69.3% |
| FY2020 | -$12.0M | -13.8% |
| FY2019 | -$10.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice